Literature DB >> 15905694

Comparison between in situ hybridization and real-time PCR technique as a means of detecting the integrated form of human papillomavirus 16 in cervical neoplasia.

Takuma Fujii1, Nobuo Masumoto, Miyuki Saito, Nobumaru Hirao, Shinichi Niimi, Makio Mukai, Akiko Ono, Shigenori Hayashi, Kaneyuki Kubushiro, Eiichi Sakai, Katsumi Tsukazaki, Shiro Nozawa.   

Abstract

Integration of the human papillomavirus (HPV) genome is thought to be one of the causes of cancer progression. However, there is controversy concerning the physical status of HPV 16 in premalignant cervical lesions, and there have been no reports on the concordance between detection of the integrated form of HPV16 by real-time PCR and by in situ hybridization. We investigated specimens of cervical intraepithelial neoplasia (CIN) and invasive carcinomas for the physical status of HPV 16 by real-time PCR and in situ hybridization. The presence of the integrated form was detected by both real-time PCR and in situ hybridization in zero of four cases of CIN1, three of six cases of CIN2, nine of 27 cases of CIN3, and two of six cases of invasive carcinomas. Integrated HPV 16 was present in some premalignant lesions but was not always present in carcinomas. The concordance rate between the two methods for the detection of the presence of the integrated form was 37 of 43 (86%) cases. Real-time PCR and in situ hybridization were found to be complementary and convenient techniques for determining the physical status of the HPV genome. We conclude that a combination of both methods is a more reliable means of assessing the physical status of the HPV genome in cervical neoplasia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15905694     DOI: 10.1097/01.pas.0000162755.84026.9f

Source DB:  PubMed          Journal:  Diagn Mol Pathol        ISSN: 1052-9551


  11 in total

1.  Comparative Performance of High-Risk Human Papillomavirus RNA and DNA In Situ Hybridization on College of American Pathologists Proficiency Tests.

Authors:  Elaine S Keung; Rhona J Souers; Julia A Bridge; William C Faquin; Rondell P Graham; Meera R Hameed; James S Lewis; Jason D Merker; Patricia Vasalos; Joel T Moncur
Journal:  Arch Pathol Lab Med       Date:  2019-09-04       Impact factor: 5.534

2.  Methylation of human papillomavirus Type 16 CpG sites at E2-binding site 1 (E2BS1), E2BS2, and the Sp1-binding site in cervical cancer samples as determined by high-resolution melting analysis-PCR.

Authors:  Elise Jacquin; Alice Baraquin; Rajeev Ramanah; Xavier Carcopino; Adrien Morel; Séverine Valmary-Degano; Ignacio G Bravo; Silvia de Sanjosé; Didier Riethmuller; Christiane Mougin; Jean-Luc Prétet
Journal:  J Clin Microbiol       Date:  2013-07-17       Impact factor: 5.948

3.  Analysis of human papillomavirus type 16 (HPV16) DNA load and physical state for identification of HPV16-infected women with high-grade lesions or cervical carcinoma.

Authors:  Maëlle Saunier; Sylvain Monnier-Benoit; Frédéric Mauny; Véronique Dalstein; Jenny Briolat; Didier Riethmuller; Bernadette Kantelip; Elisabeth Schwarz; Christiane Mougin; Jean-Luc Prétet
Journal:  J Clin Microbiol       Date:  2008-09-17       Impact factor: 5.948

4.  Ancillary testing of liquid-based cytology specimens for identification of patients at high risk of cervical cancer.

Authors:  Takuma Fujii; Miyuki Saito; Takashi Iwata; Nobumaru Hirao; Hiroshi Nishio; Akiko Ohno; Katsumi Tsukazaki; Makio Mukai; Kaori Kameyama; Daisuke Aoki
Journal:  Virchows Arch       Date:  2008-10-21       Impact factor: 4.064

5.  Evaluation of a commercialized in situ hybridization assay for detecting human papillomavirus DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma.

Authors:  Ming Guo; Yun Gong; Michael Deavers; Elvio G Silva; Yee Jee Jan; David E Cogdell; Rajyalashmi Luthra; E Lin; Hung Cheng Lai; Wei Zhang; Nour Sneige
Journal:  J Clin Microbiol       Date:  2007-10-31       Impact factor: 5.948

6.  Sequence variation of human papillomavirus type 16 and measurement of viral integration by quantitative PCR.

Authors:  Mingjun Jiang; Janet G Baseman; Laura A Koutsky; Qinghua Feng; Constance Mao; Nancy B Kiviat; Long Fu Xi
Journal:  J Clin Microbiol       Date:  2008-12-30       Impact factor: 5.948

7.  Prevalence, viral load, and physical status of HPV 16 and 18 in cervical adenosquamous carcinoma.

Authors:  Tomomi Yoshida; Takaaki Sano; Tetsunari Oyama; Tatsuya Kanuma; Toshio Fukuda
Journal:  Virchows Arch       Date:  2009-09       Impact factor: 4.064

8.  Upregulation of miR-31* is negatively associated with recurrent/newly formed oral leukoplakia.

Authors:  Wen Xiao; Zhe-Xuan Bao; Chen-Yang Zhang; Xiao-Yun Zhang; Lin-Jun Shi; Zeng-Tong Zhou; Wei-Wen Jiang
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

9.  Methylation of the L1 gene and integration of human papillomavirus 16 and 18 in cervical carcinoma and premalignant lesions.

Authors:  Francisco Israel Torres-Rojas; Luz Del Carmen Alarcón-Romero; Marco Antonio Leyva-Vázquez; Julio Ortiz-Ortiz; Miguel Ángel Mendoza-Catalán; Daniel Hernández-Sotelo; Oscar Del Moral-Hernández; Hugo Alberto Rodríguez-Ruiz; Dinorah Leyva-Illades; Eugenia Flores-Alfaro; Berenice Illades-Aguiar
Journal:  Oncol Lett       Date:  2017-12-13       Impact factor: 2.967

Review 10.  Molecular biology of cervical cancer.

Authors:  A González Martín
Journal:  Clin Transl Oncol       Date:  2007-06       Impact factor: 3.340

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.